AviadoBio
UK - LondonBiotechnology
Focus: AviadoBio is a UK-based public biotech company focused on gene therapies for neurodegenerative diseases, particularly in oncology and neurology. The company operates at an early clinical stage with a lean, emerging portfolio.
Profile data last refreshed 40m ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About AviadoBio
AI assessmentNot HiringNo open roles listed right now. Follow AviadoBio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AVB-101
Frontotemporal DementiaClinical Trials (1)
NCT06064890A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Phase 1/2Help build intelligence for AviadoBio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.